SMTL ID : 4aw5.1

Complex of the EphB4 kinase domain with an oxindole inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.33 Å

Oligo State

monomer

Ligands

1 x 30K: (3Z)-5-[(1-ethylpiperidin-4-yl)amino]-3-[(5-methoxy-1H-benzimidazol-2-yl)(phenyl)methylidene]-1,3-dihydro-2H-indol-2-one(Non-covalent)

30K.1: 16 residues within 4Å: Chain A: I.22, G.23, V.30, A.46, K.48, I.78, T.94, E.95, F.96, M.97, E.98, G.100, R.145, N.146, L.148, S.158 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.22, A:V.30, A:I.78, A:F.96, A:L.148, A:L.148 Hydrogen bonds: A:E.95, A:M.97, A:M.97

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kim, M.H. et al., The Design, Synthesis, and Biological Evaluation of Potent Receptor Tyrosine Kinase Inhibitors. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-08-01

Peptides

EPHRIN TYPE-B RECEPTOR 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

EPHRIN TYPE-B RECEPTOR 4